Overview
About the Institute
The Institute of Pharmacovigilance Sciences was established to build on the DSRU’s methodological research in pharmacovigilance and pharmacoepidemiology. The launch of the Institute marks a major expansion in the DSRU’s expertise and track record in methodological and pharmacovigilance research, both to improve existing methods and propose new ones.
The institute will study important medicine and vaccine safety issues. The work will be conducted both in-house and through collaborations.
Aim & Objectives
To advance the sciences of
pharmacovigilance and pharmacoepidemiology.
Original Research
We will undertake original research projects, independently and jointly, to study important drug safety issues.
Advancing existing methodologies
We will work to develop, improve and build upon existing methodologies used in pharmacovigilance and pharmacoepidemiology, such as Evidence-Based Medicine and benefit/risk methodology.
Collaborative approach
We will encourage collaboration, to conduct methodological research and reviews to improve existing methods and propose new ones.
Activities
Conducting high-quality methodological research
The Institute of Pharmacovigilance Sciences is predominantly focused on conducting high-quality methodological research. Its work will include evaluations of existing methods and development of new methods in pharmacovigilance. In addition, the Institute will conduct evaluation of the safety of medicines, such as ‘living’ benefit/risk evaluations and systematic reviews.
The following entities will also come under the auspices of the Institute of Pharmacovigilance Sciences:
1. DSRU International Working Group on New Developments in Pharmacovigilance
The IWG includes experts from over 20 organisations in the pharma industry and academia. The aim of the IWG is to assess the impact of new developments in biomedical sciences on signal detection and management in pharmacovigilance, aiming to improve its efficiency and protect public health.
2. The DSRU Global Pharmacovigilance Observatory
The DSRU Global Pharmacovigilance Observatory aims to bring together data about the safety of medicines and vaccines from regulatory authorities and other data sources of multiple countries into one place.
Meet the Team
Achieving the aims of the Institute
A small team of DSRU physicians, epidemiologists and biomedical scientists is dedicated to scientific work to achieve the aims of the Institute. The Institute offers honorary positions to external physicians, scientists, and experts to work on projects individually or in collaboration with others.
Samantha Lane
Head of Research for the Institute of PV Sciences andSenior Research Fellow (Research and Innovation)
Dr Alison Yeomans
Head of Innovation and Scientific Development for the Institute of PV Sciences and Research Fellow